zurück
Isoflurane (known active substance with new data exclusivity: sedation of mechanically ventilated patients during intensive care)
Subject:
- Active Substance: Isoflurane
- Name: Sedaconda®
- Therapeutic area: Sedation of mechanically ventilated patients during intensive care
- Pharmaceutical company: Sedana Medical AB
Time table:
- Start: 01.02.2022
- Final decision by G-BA: 21.07.2022
Final decision:
- No additional benefit